Oscar Health’s CEO Put $12 Million on the Line — But Not the Way You Think

Mark Bertolini just committed $11.92 million of his own money to Oscar Health. That fact alone changes the calculus for investors watching a company still burning cash but aiming for a dramatic turnaround. He now owns 10.87% of the company outright. The signal is clear: he believes Oscar can hit its aggressive 2026 targets.

But the mechanics matter. This wasn’t a classic open-market buy, where a CEO absorbs slippage and sends a thunderclap to traders. Bertolini acquired 1 million shares in a private placement — directly from Oscar Health — at $11.92 each. The company issued new shares but simultaneously withheld 1,001,001 shares from his vested performance stock units to cover taxes. The net result: Oscar pocketed $11.92 million in fresh capital, and the total share count barely moved.

No dilution. No market impact. No underwriting fees. Just cash to the balance sheet and a CEO who chose to reinvest rather than liquidate.

Related Brief1d ago

stock buybacks

Berkshire Hathaway's stock is now cheap enough for Greg Abel to buy back billions — and that changes its investment case

Berkshire Hathaway's stock is now cheap enough for Greg Abel to buy back billions — and that changes its investment case. The company's price-to-book ratio has declined to around 1.4 as the stock price moved sideways while operating earnings and investment assets continued growing. At that level, the stock is now within a range that permits repurchases under the company's buyback policy. Abel authorized a $226 million share repurchase on March 4, signaling a reactivation of the buyback program. The company could repurchase billions more shares if the stock remains at or below 1.4 times book value. Warren Buffett halted share buybacks in mid-2024 when the stock traded above 1.5 times book value, a level he considered expensive. He had long insisted that all repurchases be price-dependent: sensible at a discount, foolish at a premium. The board’s policy allows buybacks when the stock trades below intrinsic value and the company maintains ample liquidity — a threshold now met. Abel inherited a $650 billion asset portfolio and a large cash position. Berkshire's operating businesses generated $44.5 billion in earnings in 2025, providing strong internal capital generation to fund buybacks without compromising financial strength. Repurchasing shares at a discount to intrinsic value increases per-share intrinsic value for remaining shareholders, enhancing long-term returns.

Oscar ended 2025 with $396.4 million in operating losses and a $443.2 million net loss. Revenue reached $11.7 billion — up from $9.18 billion in 2024 — with membership at 3.4 million. The 2026 forecast calls for $18.7–19 billion in revenue, a 60% jump, and a medical-loss ratio held to 82.4–83.4%. Profitability hinges on both.

Related Brief1d ago

commodity trading

Senators Demand CFTC Probe Into Oil Market Trades Tied to White House Iran Moves

Trading activity in oil markets since March 23 resulted in lucrative gains for traders who positioned themselves before White House decisions on Iran, Venezuela, and tariff impositions. Senators Elizabeth Warren and Sheldon Whitehouse sent a letter to the CFTC on Thursday calling for an investigation into these unusually large commodity and equities trades. The senators requested that the CFTC provide answers to questions regarding market surveillance and investigative steps. This follows a query from Senators Mark Warner and Adam Schiff to the SEC and Defense Department Inspector General regarding similar trading activity. The CFTC enforcement director stated last month that policing insider trading is a priority.

Bertolini could have taken his vested shares, sold enough to cover taxes, and walked away richer. He didn’t. He wrote a personal check for nearly $12 million to own more. At yesterday’s closing price of $12.97, his stake is worth around $125 million.

Related Brief2d ago

equity holdings

Japan Post reduces Aflac stakes through 166,000-share sale

Japan Post Holdings Co., Ltd. now indirectly owns 51,723,100 shares of Aflac common stock. The reduction in holdings is the result of of open-market sales of Aflac common stock held indirectly through the J&A Alliance Trust. On April 8, 2026, related entities sold 166,000 shares in three tranches of 21,691 shares, 21,691 shares, 135,376 shares, and 8,933 shares. The shares were sold at weighted average prices of $111.78, $112.44, and $132.98 per { "headline": "Japan Post reduces Aflac stakes through 166,000-share sale", "chain": [ "Japan Post Holdings Co., Ltd. is a ten percent owner of Aflac Inc.", "Japan Post Holdings Co., Ltd. reported open-market sales of the Aflac Inc. common stock held indirectly through the J&A Alliance Trust.", "Related entities sold 166,000 shares of Aflac common stock in three tranches of 21,691 shares, 135,376 shares, and 8,933 shares.", "The shares were sold at weighted average prices of $111.78, $112.44, and $112.98 per share.", "The total value of the sales was $18.65 million.", "Japan Post Holdings Co., Ltd. now indirectly owns 51,723,100 shares of Aflac Inc. common stock." ], "body": "Japan Post Holdings Co., Ltd. now indirectly owns 51,723,100 shares of Aflac Inc. common stock. This reduction follows open-market sales of Aflac common stock held indirectly through the J&A Alliance Trust. On April 8, 2026, related entities sold 166,000 shares in three tranches of 21,691 shares, 135,376 shares, 1}

UnitedHealth grew Q4 2025 revenue by 12.3% to $113.2 billion. Centene and Molina posted single-digit growth. Oscar is moving faster, but it’s still unprofitable — and that’s why this transaction isn’t just compensation accounting. It’s a bet.

The market cap sits at $3.86 billion. The next data point arrives May 6, when Q1 results are due. Revenue growth above 50% and narrowing adjusted EBITDA would validate the trajectory. Until then, Bertolini’s move stands as a rare alignment: a CEO putting capital behind the math that must work. The company’s path to profitability hinges on hitting $18.7–19 billion in revenue by the end of 2026.

No dilution. No market impact. No underwriting fees. Just cash to the balance sheet and a CEO who chose to reinvest rather than liquidate.

Related Brief1d ago

stock buybacks

Berkshire Hathaway's stock is now cheap enough for Greg Abel to buy back billions — and that changes its investment case

Related Brief1d ago

commodity trading

Senators Demand CFTC Probe Into Oil Market Trades Tied to White House Iran Moves

Related Brief2d ago

equity holdings

Japan Post reduces Aflac stakes through 166,000-share sale

Oscar Health’s CEO Put $12 Million on the Line — But Not the Way You Think

Read More Analysis

These three stocks reveal how Buffett’s strategy turns market crashes into compounding engines

$70,000 in dividend income requires $2.1 million invested — not the $1 million many assume

Oscar Health’s CEO Put $12 Million on the Line — But Not the Way You Think

Read More Analysis

These three stocks reveal how Buffett’s strategy turns market crashes into compounding engines

$70,000 in dividend income requires $2.1 million invested — not the $1 million many assume

The Ledger Morning

Read More Analysis

These three stocks reveal how Buffett’s strategy turns market crashes into compounding engines

$70,000 in dividend income requires $2.1 million invested — not the $1 million many assume

The Ledger Morning

Read More Analysis

These three stocks reveal how Buffett’s strategy turns market crashes into compounding engines

$70,000 in dividend income requires $2.1 million invested — not the $1 million many assume